Key result
In patients with chronic heart failure, type 2 diabetes was associated with worse right ventricular-arterial uncoupling and a significant reduction in peak oxygen consumption compared to euglycemic patients.
Why the study?
Little information is available on the relative impact of insulin resistance and type 2 diabetes on cardiac structure, function, and cardiopulmonary performance longitudinally in chronic heart failure.
Does type 2 diabetes or insulin resistance worsen right ventricular function and exercise capacity in patients with chronic heart failure?
Observational (n=480)
Yes
Does type 2 diabetes or insulin resistance worsen right ventricular function and exercise capacity in patients with chronic heart failure?
In patients with chronic heart failure, concomitant type 2 diabetes is associated with progressive right ventricular dysfunction and worse exercise impairment compared to euglycemic patients.
T2D associated with progressive RV uncoupling and exercise decline in HF; hypothesis-generating, needs prospective confirmation before practice implications.
Background Findings from the T.O.S.CA. Registry recently reported that patients with concomitant chronic heart failure (CHF) and impairment of insulin axis (either insulin resistance- IR or diabetes mellitus- T2D) display increased morbidity and mortality. However, little information is available on the relative impact of IR and T2D on cardiac structure and function, cardiopulmonary performance, and their longitudinal changes in CHF. Methods Patients enrolled in the T.O.S.CA. Registry performed echocardiography and cardiopulmonary exercise test at baseline and at a patient-average follow-up of 36 months. Patients were divided into three groups based on the degree of insulin impairment: euglycemic without IR (EU), euglycemic with IR (IR), and T2D. Results Compared with EU and IR, T2D was associated with increased filling pressures ( E/e’ ratio : 15.9 ± 8.9, 12.0 ± 6.5, and 14.5 ± 8.1 respectively, p < 0.01) and worse right ventricular(RV)-arterial uncoupling (RVAUC) (TAPSE/PASP ratio 0.52 ± 0.2, 0.6 ± 0.3, and 0.6 ± 0.3 in T2D, EU and IR, respectively, p < 0.05). Likewise, impairment in peak oxygen consumption (peak VO2) in TD2 vs EU and IR patients was recorded (respectively, 15.8 ± 3.8 mL/Kg/min, 18.4 ± 4.3 mL/Kg/min and 16.5 ± 4.3 mL/Kg/min, p < 0.003). Longitudinal data demonstrated higher deterioration of RVAUC, RV dimension, and peak VO2 in the T2D group (+ 13% increase in RV dimension, -21% decline in TAPSE/PAPS ratio and − 20% decrease in peak VO2). Conclusion The higher risk of death and CV hospitalizations exhibited by HF-T2D patients in the T.O.S.CA. Registry is associated with progressive RV ventricular dysfunction and exercise impairment when compared to euglycemic CHF patients, supporting the pivotal importance of hyperglycaemia and right chambers in HF prognosis. Trial registration ClinicalTrials.gov identifier: NCT023358017
No takes yet. Share an insight, caveat, or question.
Salzano et al. (2022) conducted an observational in Chronic Heart Failure (n=480). Type 2 Diabetes and Insulin Resistance vs. Euglycemic patients was evaluated on Peak oxygen consumption (peak VO2) (p=<0.003). In patients with chronic heart failure, type 2 diabetes was associated with worse right ventricular-arterial uncoupling and a significant reduction in peak oxygen consumption compared to euglycemic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: